⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2434044 | 0.96 | — | — | |
| SCHEMBL7462675 | 0.86 | — | — | |
| SCHEMBL12453126 | 0.86 | — | — | |
| SCHEMBL15160440 | 0.85 | — | — | |
| SCHEMBL15601188 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL21879698 | 0.83 | KDM4E (0.31) | — | |
| SCHEMBL16874281 | 0.83 | KDM4E (0.31) | — | |
| Hydrochloric Acid SCHEMBL25279591 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL1936903 | 0.81 | KDM4E (0.30) | — | |
| SCHEMBL7742213 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117050256-A | Polymerizable composition | 华为技术有限公司 | 2023-11-14 | — | — | CN | claimed |
| EP-1439182-B1 | Imidosilane compositions | GEN ELECTRIC (US) | 2007-02-14 | — | — | EP | claimed |
| US-12509444-B2 | Compounds and methods for CD73 modulation and indications therefor | PLEXXIKON INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250346922-A1 | COMPOUNDS FOR IMPROVEMENT OF VIRAL PRODUCTION | TENAYA THERAPEUTICS INC (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250074875-A1 | AT2R ANTAGONISTS AND USES THEREOF | ELI LILLY AND COMPANY | 2025-03-06 | — | — | US | disclosed |
| EP-4139287-B1 | SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION | BAYER AG (DE) | 2025-02-26 | — | — | EP | disclosed |
| US-12201617-B2 | HDAC6 inhibitors for treatment of metabolic disease and HFpEF | TENAYA THERAPEUTICS, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| US-12122750-B2 | AT2R antagonists and uses thereof | ELI LILLY AND COMPANY (US) | 2024-10-22 | — | — | US | disclosed |
| US-12116369-B2 | Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activators | Bial—R&D Investments, S.A. (PT) | 2024-10-15 | — | — | US | disclosed |
| US-20240269137-A1 | HDAC6 INHIBITORS FOR TREATMENT OF DILATED CARDIOMYOPATHY | TENAYA THERAPEUTICS, INC. | 2024-08-15 | — | — | US | disclosed |
| US-20240252502-A1 | HDAC6 INHIBITORS FOR TREATMENT OF METABOLIC DISEASE AND HFPEF | TENAYA THERAPEUTICS, INC. | 2024-08-01 | — | — | US | disclosed |
| US-20080182750-A1 | Cyano Anthranilamide Insecticides | SYNGENTA CROP PROTECTION, INC. (US) | 2008-07-31 | — | — | US | disclosed |
| US-20080182750-A1 | Cyano Anthranilamide Insecticides | SYNGENTA CROP PROTECTION, INC. (US) | 2008-07-31 | — | — | US | disclosed |
| US-20080182750-A1 | Cyano Anthranilamide Insecticides | SYNGENTA CROP PROTECTION, INC. (US) | 2008-07-31 | — | — | US | disclosed |
| WO-2008031549-A1 | PROCESS FOR THE PREPARATION OF ANTHRANILAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2008-03-20 | — | — | WO | disclosed |
| WO-2008031548-A1 | PROCESS FOR THE PREPARATION OF ANTHRANILAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2008-03-20 | — | — | WO | disclosed |
| EP-1900730-A1 | Process for the preparation of anthranilamide derivatives | Syngeta Participations AG (CH) | 2008-03-19 | — | — | EP | disclosed |
| EP-1871760-A1 | CYANO ANTHRANILAMIDE INSECTICIDES | Syngeta Participations AG (CH) | 2008-01-02 | — | — | EP | disclosed |
| WO-2007093402-A1 | PESTICIDES CONTAINING A BICYCLIC BISAMIDE STRUCTURE | SYNGENTA PARTICIPATIONS AG (CH) | 2007-08-23 | — | — | WO | disclosed |
| WO-2006111341-A1 | CYANO ANTHRANILAMIDE INSECTICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2006-10-26 | — | — | WO | disclosed |